If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: Medical Device Network
Synapse BiomedicalInc: FDA approves Synapse's NeuRx DPS to treat patients with stable SCI
NeuRx DPS can be used to help patients 18 years and older to breathe without the support of a mechanical ventilator. The post FDA approves Synapse's NeuRx DPS to treat patients with stable SCI appeared first on Medical Device Network.
Read full article »
Synapse BiomedicalInc's Competitors
|
Synapse BiomedicalInc's News
|
Synapse BiomedicalInc's Financials
Follow
Followers on Owler
5
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
President & CEO
Anthony R. Ignagni
CEO Approval Rating
90/100
Weigh In
Read more
See Synapse BiomedicalInc company profile »